Palatin to Report Fourth Quarter and Fiscal Year End 2024 Results
Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2024 operating results on Tuesday, October 1, 2024, before the U.S. financial markets open. The company will host a conference call and live audio webcast at 11:00 AM Eastern Time on the same day, featuring a review of operating results and updates on programs under development.
The press release will be available at 7:30 a.m. ET, followed by the live conference call at 11:00 a.m. ET. A replay of the call will be accessible from October 1 to October 15, 2024. Investors can access the webcast through Palatin's website.
Palatin is a biopharmaceutical company focusing on first-in-class medicines based on melanocortin receptor systems for treating diseases with significant unmet medical needs.
Palatin Technologies, Inc. (NYSE American: PTN) annuncerà i suoi risultati operativi del quarto trimestre e della fine dell'anno fiscale 2024 martedì 1 ottobre 2024, prima dell'apertura dei mercati finanziari statunitensi. L'azienda ospiterà una call di conferenza e un webcast audio dal vivo alle 11:00 ora orientale dello stesso giorno, con una revisione dei risultati operativi e aggiornamenti sui programmi in via di sviluppo.
Il comunicato stampa sarà disponibile alle 7:30 a.m. ET, seguito dalla conferenza telefonica dal vivo alle 11:00 a.m. ET. Una registrazione della chiamata sarà accessibile dal 1 ottobre al 15 ottobre 2024. Gli investitori possono accedere al webcast attraverso il sito web di Palatin.
Palatin è una società biofarmaceutica che si concentra su medicinali di prima classe basati su sistemi di recettori melanocortinici per trattare malattie con esigenze mediche insoddisfatte significative.
Palatin Technologies, Inc. (NYSE American: PTN) anunciará sus resultados operativos del cuarto trimestre y del año fiscal 2024 el martes 1 de octubre de 2024, antes de la apertura de los mercados financieros de EE. UU. La empresa llevará a cabo una conferencia telefónica y una transmisión de audio en vivo a las 11:00 AM hora del Este el mismo día, que incluirá una revisión de los resultados operativos y actualizaciones sobre los programas en desarrollo.
El comunicado de prensa estará disponible a las 7:30 a.m. ET, seguido de la conferencia telefónica en vivo a las 11:00 a.m. ET. Una grabación de la llamada estará accesible desde el 1 de octubre hasta el 15 de octubre de 2024. Los inversores pueden acceder al webcast a través del sitio web de Palatin.
Palatin es una empresa biofarmacéutica que se centra en medicamentos de primera clase basados en sistemas de receptores melanocortínicos para tratar enfermedades con necesidades médicas significativas no satisfechas.
팔라틴 테크놀로지스, 인크. (NYSE American: PTN)는 미국 금융 시장이 열리기 전에 2024 회계연도 4분기 및 연말 운영 결과를 발표할 예정입니다. 회사는 같은 날 동부 표준시로 오전 11시에 전화 회의 및 라이브 오디오 웹캐스트를 개최하며, 운영 결과와 개발 중인 프로그램에 대한 업데이트를 제공합니다.
보도 자료는 동부 표준시로 오전 7시 30분에 제공되며, 이어서 오전 11시에 라이브 전화 회의가 진행됩니다. 이 회의의 재생 녹음은 2024년 10월 1일부터 10월 15일까지 이용 가능합니다. 투자자는 팔라틴의 웹사이트를 통해 웹캐스트에 접근할 수 있습니다.
팔라틴은 생물 제약 회사로, 중요한 의학적 요구가 충족되지 않은 질병 치료를 위한 멜라노코르틴 수용체 시스템 기반의 1급 약물에 중점을 두고 있습니다.
Palatin Technologies, Inc. (NYSE American: PTN) annoncera ses résultats opérationnels du quatrième trimestre et de l'exercice fiscal 2024 le mardi 1er octobre 2024, avant l'ouverture des marchés financiers américains. L'entreprise organisera une conférence téléphonique et un webcast audio en direct à 11h00, heure de l'Est, le même jour, qui comprendra un bilan des résultats opérationnels et des mises à jour sur les programmes en cours de développement.
Le communiqué de presse sera disponible à 7h30 ET, suivi de la conférence téléphonique en direct à 11h00 ET. Un enregistrement de l'appel sera accessible du 1er octobre au 15 octobre 2024. Les investisseurs peuvent accéder au webcast via le site Web de Palatin.
Palatin est une entreprise biopharmaceutique axée sur des médicaments de première classe basés sur des systèmes de récepteurs mélanocortiniques pour traiter des maladies présentant des besoins médicaux significatifs non satisfaits.
Palatin Technologies, Inc. (NYSE American: PTN) wird am Dienstag, den 1. Oktober 2024, vor der Eröffnung der US-Finanzmärkte seine Ergebnisse für das vierte Quartal und das Geschäftsjahr 2024 bekannt geben. Das Unternehmen wird am selben Tag um 11:00 Uhr Eastern Time eine Telefonkonferenz und einen Live-Audio-Webcast veranstalten, in dem die Betriebsergebnisse und Updates zu den laufenden Programmen vorgestellt werden.
Die Pressemitteilung wird um 7:30 Uhr ET verfügbar sein, gefolgt von der Live-Telefonkonferenz um 11:00 Uhr ET. Eine Aufzeichnung des Anrufs wird vom 1. Oktober bis zum 15. Oktober 2024 zugänglich sein. Investoren können über die Website von Palatin auf den Webcast zugreifen.
Palatin ist ein biopharmazeutisches Unternehmen, das sich auf erstklassige Medikamente auf der Basis von Melanocortin-Rezeptorsystemen zur Behandlung von Krankheiten mit erheblichen unerfüllten medizinischen Bedürfnissen konzentriert.
- Timely reporting of quarterly and annual financial results
- Providing investor access through conference call and webcast
- Focus on first-in-class medicines for unmet medical needs
- None.
Teleconference and Webcast to be held on October 1, 2024
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on October 1, 2024 at 11:00 AM Eastern Time. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
Q4 & Fiscal Year End 2024 Results Press Release | 10/01/2024 at 7:30 a.m. ET |
Q4 & Fiscal Year End 2024 Conference Call-Live | 10/01/2024 at 11:00 a.m. ET |
US Toll Free Dial-In Number: | 1-888-506-0062 |
International Dial-In Number: | 1-973-528-0011 |
Participant Access Code: | 252326 |
Q4 & Fiscal Year End 2024 Conference Call-Replay | 10/01/2024-10/15/2024 |
US Toll Free Dial-In Number: | 1-877-481-4010 |
International Dial-In Number: | 1-919-882-2331 |
Participant Access Code: | 51290 |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-fourth-quarter-and-fiscal-year-end-2024-results-302259586.html
SOURCE Palatin Technologies, Inc.
FAQ
When will Palatin Technologies (PTN) release its Q4 and fiscal year 2024 results?
What time is Palatin's (PTN) Q4 2024 earnings conference call?
How can investors access Palatin's (PTN) Q4 2024 earnings webcast?
What is the main focus of Palatin Technologies (PTN)?
